A recent case in India reveals the various ways in which pharmaceutical patents can be challenged, as Neeti Wilson, Arpita Kulshreshtha and Gitika Suri of Anand and Anand report.
- LSIPR 50 2018: Naoko Munakata 30-07-2018
- LSIPR 50 2018: Changyu Shen 27-07-2018
- LSIPR 50 2018: Sung Yunmo 24-07-2018
- LSIPR 50 2018: Levelling the medicines playing field 02-07-2018
- Protecting patients, and patents 04-06-2018
Latest asia news
Gilead Sciences, a biopharmaceutical company based in the US, has entered into a licensing and collaboration agreement with South Korean healthcare company Yuhan.